Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 273
Filter
1.
J Med Chem ; 67(8): 6705-6725, 2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38596897

ABSTRACT

Cefiderocol is the first approved catechol-conjugated cephalosporin against multidrug-resistant Gram-negative bacteria, while its application was limited by poor chemical stability associated with the pyrrolidinium linker, moderate potency against Klebsiella pneumoniae and Acinetobacter baumannii, intricate procedures for salt preparation, and potential hypersensitivity. To address these issues, a series of novel catechol-conjugated derivatives were designed, synthesized, and evaluated. Extensive structure-activity relationships and structure-metabolism relationships (SMR) were conducted, leading to the discovery of a promising compound 86b (Code no. YFJ-36) with a new thioether linker. 86b exhibited superior and broad-spectrum in vitro antibacterial activity, especially against A. baumannii and K. pneumoniae, compared with cefiderocol. Potent in vivo efficacy was observed in a murine systemic infection model. Furthermore, the physicochemical stability of 86b in fluid medium at pH 6-8 was enhanced. 86b also reduced potential the risk of allergy owing to the quaternary ammonium linker. The improved properties of 86b supported its further research and development.


Subject(s)
Anti-Bacterial Agents , Catechols , Drug Design , Gram-Negative Bacteria , Microbial Sensitivity Tests , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Catechols/chemistry , Catechols/pharmacology , Catechols/chemical synthesis , Animals , Structure-Activity Relationship , Mice , Gram-Negative Bacteria/drug effects , Klebsiella pneumoniae/drug effects , Acinetobacter baumannii/drug effects , beta-Lactams/pharmacology , beta-Lactams/chemical synthesis , beta-Lactams/chemistry , Cephalosporins/pharmacology , Cephalosporins/chemical synthesis , Cephalosporins/chemistry , Drug Discovery
2.
ACS Appl Mater Interfaces ; 14(4): 6212-6220, 2022 Feb 02.
Article in English | MEDLINE | ID: mdl-35050591

ABSTRACT

Translating fundamental studies of marine mussel adhesion into practical mussel-inspired wet adhesives remains an important technological challenge. To adhere, mussels secrete adhesive proteins rich in the catecholic amino acid 3,4-dihydroxyphenylalanine (Dopa) and positively charged lysine. Consequently, numerous synthetic adhesives incorporating catecholic and cationic functionalities have been designed. However, despite widespread research, uncertainties remain about the optimal design of synthetic mussel-inspired adhesives. Here, we present a study of the adhesion of mussel-inspired pressure-sensitive adhesives. We explore the effects of catechol content, molecular architecture, and solvent quality on pressure-sensitive adhesive (PSA) adhesion and cohesion measured in a surface forces apparatus. Our findings demonstrate that the influence of catechol content depends on the choice of solvent and that adhesive performance is dictated by film composition rather than molecular architecture. Our results also highlight the importance of electrostatic and hydrophobic interactions for adhesion and cohesion in aqueous environments. Together, our findings contribute to an improved understanding of the interplay between materials chemistry, environmental conditions, and adhesive performance to facilitate the design of bioinspired wet adhesives.


Subject(s)
Acrylic Resins/chemistry , Adhesives/chemistry , Catechols/chemistry , Acrylic Resins/chemical synthesis , Adhesiveness , Adhesives/chemical synthesis , Catechols/chemical synthesis , Ethanol/chemistry , Pressure , Solvents/chemistry , Water/chemistry
3.
ACS Appl Mater Interfaces ; 14(1): 236-244, 2022 Jan 12.
Article in English | MEDLINE | ID: mdl-34935360

ABSTRACT

Gelatin is one of the most versatile biopolymers in various biomedical applications. A gelatin derivative gelatin-catechol (Gel-C) was developed in this study to further optimize its chemical and physical properties such as thermal reversibility and injectability. We found that Gel-C remains in a solution state at room temperature, and the temperature-dependent gelation capability of gelatin is well preserved in Gel-C. Its gel-forming temperature decreased to about 10 °C (about 30 °C for gelatin), and a series of gelatin derivatives with different gel-forming temperatures (10-30 °C) were formed by mixing gelatin and Gel-C in different ratios. Additionally, irreversible Gel-C hydrogels could be made without the addition of external stimuli by combining the physical cross-linking of gelatin and the chemical cross-linking of catechol. At the same time, properties of Gel-C hydrogels such as thermal reversibility and injectability could be manipulated by controlling the temperature and pH of the precursor solution. By simulating the formation of an irreversible Gel-C hydrogel in vivo, an in situ gelling system was fabricated by lowering the local temperature of the hydrogel with cold shock, thus realizing targeted and localized molecular delivery with prolonged retention time. This simple system integrated with the temperature responsiveness of gelatin and chemical cross-linking of catechol groups thus provides a promising platform to fabricate an in situ gelling system for drug delivery.


Subject(s)
Catechols/chemistry , Delayed-Action Preparations/chemistry , Gelatin/chemistry , Hydrogels/chemistry , Animals , Catechols/administration & dosage , Catechols/chemical synthesis , Catechols/toxicity , Cell Line , Cold Temperature , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/chemical synthesis , Delayed-Action Preparations/toxicity , Drug Liberation , Fluorescein-5-isothiocyanate/analogs & derivatives , Fluorescein-5-isothiocyanate/chemistry , Gelatin/administration & dosage , Gelatin/chemical synthesis , Gelatin/toxicity , Hydrogels/administration & dosage , Hydrogels/chemical synthesis , Hydrogels/toxicity , Hydrogen-Ion Concentration , Injections, Subcutaneous , Male , Mice, Nude , Phase Transition/drug effects , Serum Albumin, Bovine/chemistry , Transition Temperature
4.
Chem Biodivers ; 18(12): e2100650, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34599795

ABSTRACT

6-Gingerol (1) is one of the major components in ginger and developing new synthetic methodologies could bring semisynthetic analogs with improved therapeutic properties. Towards this, multigram scale isolation of 6-gingerol with excellent purity was optimized using a simple and robust extraction, followed by column purification. Synthesis of 6-gingerdione, 7 from 6-gingerol was then achieved through selective -OTBDMS protection, DMP oxidation and deprotection reaction sequence for the first time. Compounds 1, 7 and 8 (dehydrozingerone) exhibited excellent cell-free antioxidant properties in DPPH, ABTS, superoxide radical scavenging assay and H2 O2 assay at 10-50 µM concentrations. The hemolytic study suggests that up to 50 µM, all three compounds did not exhibit toxicity to human erythrocytes. When H2 O2 treated zebrafish larvae groups (96hpf) were exposed to compounds 1, 7 and 8, it increases the SOD (19, 19.1 and 18.7 U/mg protein), CAT (18.1, 16.5, and 15.8 µmol/mg levels and decreases the lipid peroxidation level (13, 15 and 18 nmol/mg protein), respectively. In vivo ROS levels and degree of cell death were studied using DCFDA and Acridine orange assays. Compounds 1, 7 and 8 decreases the ROS and cell death level significantly. Taken together, compounds 1, 7 and 8 exhibit excellent antioxidant properties, counteract H2 O2 induced oxidative stress, reduces cell death in zebrafish larvae.


Subject(s)
Antioxidants/pharmacology , Catechols/pharmacology , Fatty Alcohols/pharmacology , Guaiacol/analogs & derivatives , Reactive Oxygen Species/metabolism , Animals , Antioxidants/chemical synthesis , Antioxidants/chemistry , Benzothiazoles/antagonists & inhibitors , Biphenyl Compounds/antagonists & inhibitors , Catechols/chemical synthesis , Catechols/chemistry , Cell Death/drug effects , Fatty Alcohols/chemical synthesis , Fatty Alcohols/chemistry , Zingiber officinale/chemistry , Guaiacol/chemical synthesis , Guaiacol/chemistry , Guaiacol/pharmacology , Humans , Hydrogen Peroxide/pharmacology , Oxidative Stress/drug effects , Picrates/antagonists & inhibitors , Sulfonic Acids/antagonists & inhibitors , Zebrafish
5.
AAPS PharmSciTech ; 22(5): 157, 2021 May 18.
Article in English | MEDLINE | ID: mdl-34008089

ABSTRACT

The apoptotic, cytotoxic, and cytostatic activities for [10]-gingerol in triple-negative breast cancer cells (TNBCs) were already reported. However, despite these important antitumor activities, the compound has the disadvantage to have a hydrophobic characteristic, hindering in vivo administration. To surpass this issue, in this study we have created a [10]-gingerol-loaded nanoemulsion (10GNE) in order to increase the stability and solubility of the compound. The nanoemulsion was characterized and tested for its cytotoxic, cytostatic, and apoptotic effects on a panel of murine and human TNBC cell lines, as well as non-tumor cells, and compared with a [10]-gingerol-free nanoemulsion (NE) and with [10]-gingerol itself. Except for the murine 4T1.13 cell line, the IC50 of the free 10G molecule, after 72 h of incubation, was higher in all cell lines tested, both murine and human, demonstrating therefore the efficacy of the 10GNE regarding cytotoxicity. In murine tumor cells, 60 µM 10GNE was able to arrest cell cycle at sub-G0 phase and induce apoptosis, leading to 48% and 78% of total cell death in 4T1.13 and 4T1Br4 murine tumor cells, respectively. This represents an improvement compared to 10G-free molecule that only induced 74% of total apoptosis at 100 µM in 4T1Br4 cells. Taken together, our results show that nanoformulation preserved the [10]-gingerol cytotoxic and cytostatic properties and improved its apoptotic function on murine TNBC cell lines. These data open new perspectives to a more suitable drug-delivery approach for [10]-gingerol for TNBC treatment that should be further demonstrated using in vivo assays.


Subject(s)
Catechols/administration & dosage , Drug Delivery Systems/methods , Fatty Alcohols/administration & dosage , Nanospheres/administration & dosage , Triple Negative Breast Neoplasms , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Apoptosis/physiology , BALB 3T3 Cells , Catechols/chemical synthesis , Cell Division/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Emulsions , Fatty Alcohols/chemical synthesis , Humans , Mice , Nanospheres/chemistry , Triple Negative Breast Neoplasms/drug therapy
6.
J Enzyme Inhib Med Chem ; 36(1): 819-830, 2021 Dec.
Article in English | MEDLINE | ID: mdl-33757387

ABSTRACT

Compounds containg catechol or bisphosphonate were tested as inhibitors of the zinc metalloproteases, thermolysin (TLN), pseudolysin (PLN) and aureolysin (ALN) which are bacterial virulence factors, and the human matrix metalloproteases MMP-9 and -14. Inhibition of virulence is a putative strategy in the development of antibacterial drugs, but the inhibitors should not interfere with human enzymes. Docking indicated that the inhibitors bound MMP-9 and MMP-14 with the phenyl, biphenyl, chlorophenyl, nitrophenyl or methoxyphenyl ringsystem in the S1'-subpocket, while these ringsystems entered the S2'- or S1 -subpockets or a region involving amino acids in the S1'- and S2'-subpockets of the bacterial enzymes. An arginine conserved among the bacterial enzymes seemed to hinder entrance deeply into the S1'-subpocket. Only the bisphosphonate containing compound RC2 bound stronger to PLN and TLN than to MMP-9 and MMP-14. Docking indicated that the reason was that the conserved arginine (R203 in TLN and R198 in PLN) interacts with phosphate groups of RC2.


Subject(s)
Anti-Bacterial Agents/pharmacology , Catechols/pharmacology , Diphosphonates/pharmacology , Matrix Metalloproteinase Inhibitors/pharmacology , Metalloendopeptidases/antagonists & inhibitors , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Bacteria/enzymology , Catechols/chemical synthesis , Catechols/chemistry , Diphosphonates/chemical synthesis , Diphosphonates/chemistry , Humans , Matrix Metalloproteinase Inhibitors/chemical synthesis , Matrix Metalloproteinase Inhibitors/chemistry , Metalloendopeptidases/metabolism , Microbial Sensitivity Tests , Models, Molecular , Molecular Structure , THP-1 Cells
7.
ACS Appl Mater Interfaces ; 13(8): 9729-9738, 2021 Mar 03.
Article in English | MEDLINE | ID: mdl-33599495

ABSTRACT

Intracerebral hemorrhage (ICH) will be accompanied by the overload of iron and reactive oxygen species (ROS) following hematoma clearance. Although deferoxamine (DFO) has been widely utilized as a clinical first-line siderophore to remove the iron overload, the ROS-inducing damage still greatly limits the therapeutic effect of DFO. To address this issue, we designed and fabricated a series of dual-functional macromolecular nanoscavengers featuring high-density DFO units and catechol moieties. Note that the former units could effectively remove the iron overload, while the latter ones could efficiently deplete the ROS. The resulting nanoscavengers efficiently down-regulate the iron and ROS levels as well as significantly reduce the cell death in both iron-overloaded RAW 264.7 cells and the ICH mice model. This work suggests a novel clue for the ICH-ameliorated iron-depleting interventional therapeutic regimen.


Subject(s)
Antioxidants/therapeutic use , Cerebral Hemorrhage/drug therapy , Iron Overload/drug therapy , Neuroprotective Agents/therapeutic use , Polymers/therapeutic use , Siderophores/therapeutic use , Animals , Antioxidants/chemical synthesis , Brain/drug effects , Brain/metabolism , Brain/physiopathology , Catechols/chemical synthesis , Catechols/therapeutic use , Cerebral Hemorrhage/chemically induced , Cerebral Hemorrhage/complications , Cerebral Hemorrhage/physiopathology , Collagenases , Deferoxamine/analogs & derivatives , Deferoxamine/therapeutic use , Iron/metabolism , Iron Overload/etiology , Iron Overload/physiopathology , Male , Mice , Mice, Inbred BALB C , Neuroprotective Agents/chemical synthesis , Polymers/chemical synthesis , RAW 264.7 Cells , Reactive Oxygen Species/metabolism , Siderophores/chemical synthesis
8.
Anticancer Agents Med Chem ; 21(4): 428-432, 2021.
Article in English | MEDLINE | ID: mdl-32951584

ABSTRACT

Cancer is one of the most lethal diseases in the world. Because of the high death rate associated with cancer and the side effects of chemotherapy and radiation therapy, patients require alternative strategies for its treatment. Ginger (Zingiber officinale) has enormous medicinal properties and health benefits. In this review, we discuss the basic mechanism by which gingerol (an active component of ginger) modulates a variety of cell signaling pathways linked to cancer, including Nuclear Factors (NF-κB), Signal Transducer and Activator of Transcription 3 (STAT3), Activator Protein-1 (AP-1), ß-catenin, Growth Factors Receptors (EGFR, VEGFR); Mitogen-Activated Protein Kinases (MAPK) and pro-inflammatory mediators (TNF-α and COX-2). Both in vitro and in vivo studies support the role of gingerol in cancer. The efficacy of gingerol by clinical trials has also been reported. Importantly, natural agents are already in clinical trials against various kinds of cancer. An effort has been made through this comprehensive review to highlight the recent developments and milestones achieved in cancer therapies via studies based on different cell lines using gingerol.


Subject(s)
Antineoplastic Agents/pharmacology , Catechols/pharmacology , Fatty Alcohols/pharmacology , Neoplasms/drug therapy , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Apoptosis/drug effects , Catechols/chemical synthesis , Catechols/chemistry , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Screening Assays, Antitumor , Fatty Alcohols/chemical synthesis , Fatty Alcohols/chemistry , Humans , Neoplasms/metabolism , Neoplasms/pathology
9.
Behav Pharmacol ; 31(8): 716-727, 2020 12.
Article in English | MEDLINE | ID: mdl-32925227

ABSTRACT

Isocordoin (1), a chalcone isolated from different plants, has been found to present a range of interesting biological properties. This study aimed to evaluate the anti-hypersensitive and anti-inflammatory effects of isocordoin (1) and several natural and semisynthetic derivatives (2-10). Initial evaluation of (1), dihydroisocordoin (2) and six semisynthetic derivatives (3-8) in the inhibition of abdominal writhes induced by acetic acid model showed that only isocordoin dimethylether (5) caused more than 70% of inhibition. Further evaluation of 5 for its anti-oedematogenic activity and anti-hypersensitivity effect induced by carrageenan, lipopolysaccharide (LPS), bradykinin (BK), prostaglandin E2 (PGE2), and epinephrine showed that isocordoin dimethylether (5) presented a discrete inhibition of carrageenan- and LPS-induced hypersensitivity, and of carrageenan-induced paw oedema, and that it was able to significantly reduce both the oedema and hypersensitivity induced by BK. Furthermore, when tested in the PGE2 model, 5 interfered only with the paw-oedema, without showing any effect against the paw-hypersensitivity. Evaluation of the natural isocordoin (1), together with the semisynthetic derivatives isocordoin dimethylether (5), isocordoin methylether (9), and dihydroisocordoin methylether (10) in the BK-induced oedema and hypersensitivity showed that the monoalkylated derivatives 10 and 9 had the strongest antinociceptive activity. The results of this investigation indicate that both monoalkylation of the C-4' phenolic hydroxyl group and reduction of the double bond in the α,ß-unsaturated system of the chalcone skeleton favor activity.


Subject(s)
Catechols/chemical synthesis , Catechols/pharmacology , Analgesics/pharmacology , Animals , Anti-Inflammatory Agents/pharmacology , Antihypertensive Agents/pharmacology , Catechols/metabolism , Chalcone/pharmacology , Chalcones/pharmacology , Edema/drug therapy , Fabaceae/metabolism , Female , Hyperalgesia/drug therapy , Male , Mice , Plant Extracts/pharmacology
10.
Chem Pharm Bull (Tokyo) ; 68(5): 447-451, 2020.
Article in English | MEDLINE | ID: mdl-32378542

ABSTRACT

Catechol O-methyltransferase (COMT) is known as an important drug-target protein in the field of Parkinson's disease. All clinically approved COMT inhibitors bring a 5-substituted-3-nitrocatechol ring as a pharmacophore, and they bind to COMT with S-adenosylmethionine (SAM) and an Mg2+ ion to form a quaternary complex (COMT/SAM/Mg2+/inhibitor). However, structural information about such quaternary complexes is only available for a few inhibitors. Here, a new crystal structure of COMT complexed with nitecapone (5), SAM and Mg2+ is revealed. Comparison of the structures of these complexes indicates that conformation of the catechol binding pocket is almost constant regardless of structure of the inhibitors. The only restriction of the side chain of inhibitors (i.e., the substituent at the 5-position of 3-nitrocatechol) seems to be that it does not make steric repulsion with COMT. However, recent crystallographic and biochemical studies suggest that COMT is a flexible protein, and its conformational flexibility seems crucial for its catalytic process. Based on this information, implications of these quaternary inhibitor complexes were investigated. Met 40 in the α2α3-loop makes atomic contacts with SAM or S-adenosylhomocysteine and the 3-position of the catechol inhibitor. This interaction seems to play a critical role in the affinity of the inhibitor and to stabilize the COMT/SAM/Mg2+/nitrocatechol inhibitor complex by fixing the flexible α2α3-loop.


Subject(s)
Catechol O-Methyltransferase Inhibitors/pharmacology , Catechol O-Methyltransferase/metabolism , Catechols/pharmacology , Pentanones/pharmacology , Catechol O-Methyltransferase/isolation & purification , Catechol O-Methyltransferase Inhibitors/chemical synthesis , Catechol O-Methyltransferase Inhibitors/chemistry , Catechols/chemical synthesis , Catechols/chemistry , Crystallography, X-Ray , Dose-Response Relationship, Drug , Humans , Models, Molecular , Molecular Structure , Pentanones/chemical synthesis , Pentanones/chemistry , Structure-Activity Relationship
11.
Arch Pharm (Weinheim) ; 353(6): e2000013, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32301169

ABSTRACT

Catechol-containing imidazolium (four) and benzimidazolium chlorides (eight) were synthesized to evaluate their antimicrobial properties. All the compounds were fully characterized using 1 H and 13 C nuclear magnetic resonance, liquid chromatography-mass spectrometry, infrared spectroscopic methods, and elemental analyses. Antimicrobial activities of the compounds were tested against the bacteria Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Enterococcus faecalis, and the fungal strains Candida albicans and Candida glabrata, and promising results were achieved. The two most important benzyl-substituted benzimidazolium chlorides, 3l and 3k, showed comparable activity to vancomycin against MRSA.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Benzimidazoles/pharmacology , Catechols/pharmacology , Imidazoles/pharmacology , Acinetobacter baumannii/drug effects , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Benzimidazoles/chemical synthesis , Benzimidazoles/chemistry , Candida albicans/drug effects , Candida glabrata/drug effects , Catechols/chemical synthesis , Catechols/chemistry , Dose-Response Relationship, Drug , Enterococcus faecalis/drug effects , Escherichia coli/drug effects , Imidazoles/chemical synthesis , Imidazoles/chemistry , Klebsiella pneumoniae/drug effects , Methicillin-Resistant Staphylococcus aureus/drug effects , Microbial Sensitivity Tests , Molecular Structure , Pseudomonas aeruginosa/drug effects , Staphylococcus aureus/drug effects , Structure-Activity Relationship
12.
Bioorg Med Chem Lett ; 30(12): 127188, 2020 06 15.
Article in English | MEDLINE | ID: mdl-32299731

ABSTRACT

Literature reports that chalcones inhibit the monoamine oxidase (MAO) enzymes, mostly with specificity for the MAO-B isoform, while nitrocatechol compounds are established inhibitors of catechol-O-methyltransferase (COMT). Based on this, nitrocatechol derivatives of chalcone have been proposed to represent dual-target-directed compounds that may inhibit both MAO-B and COMT. Both these enzymes play key roles in the metabolism of dopamine and levodopa, and inhibitors are thus relevant to the treatment of Parkinson's disease. The present study expands on the discovery of dual MAO-B/COMT inhibitors by synthesising additional nitrocatechol derivatives of chalcones which include heterocyclic derivatives, and converting them to the corresponding pyrazoline derivatives. The newly synthesised chalcone and pyrazoline compounds were evaluated as inhibitors of human MAO and rat COMT, and the inhibition potencies were expressed as IC50 values. A pyrazoline derivative, compound 8b, was the most potent COMT inhibitor with an IC50 value of 0.048 µM. This is more potent than the reference COMT inhibitor, entacapone, which has an IC50 value of 0.23 µM. The results indicated that the pyrazoline derivatives (IC50 = 0.048-0.21 µM) are more potent COMT inhibitors than the chalcones (IC50 = 0.14-0.29 µM). Unfortunately, the chalcone and pyrazoline derivatives were weak MAO inhibitors with IC50 values > 41.4 µM. This study concludes that the nitrocatechol derivatives investigated here are promising COMT inhibitors, while not being suitable as MAO inhibitors. Using molecular docking, potential binding modes and interactions of selected inhibitors with COMT are proposed.


Subject(s)
Catechol O-Methyltransferase Inhibitors/pharmacology , Catechol O-Methyltransferase/metabolism , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Animals , Catechol O-Methyltransferase Inhibitors/chemical synthesis , Catechol O-Methyltransferase Inhibitors/chemistry , Catechols/chemical synthesis , Catechols/chemistry , Catechols/pharmacology , Chalcones/chemical synthesis , Chalcones/chemistry , Chalcones/pharmacology , Dose-Response Relationship, Drug , Humans , Molecular Structure , Monoamine Oxidase Inhibitors/chemical synthesis , Monoamine Oxidase Inhibitors/chemistry , Nitro Compounds/chemical synthesis , Nitro Compounds/chemistry , Nitro Compounds/pharmacology , Pyrazoles/chemical synthesis , Pyrazoles/chemistry , Pyrazoles/pharmacology , Rats , Structure-Activity Relationship
13.
Molecules ; 25(8)2020 Apr 12.
Article in English | MEDLINE | ID: mdl-32290617

ABSTRACT

New polyfunctional sterically hindered 3,5-di-tert-butylcatechols with an additional phenolic group in the sixth position connected by a bridging sulfur atom-(6-(CH2-S-tBu2Phenol)-3,5-DBCat)H2 (L1), (6-(S-tBu2Phenol)-3,5-DBCat)H2 (L2), and (6-(S-Phenol)-3,5-DBCat)H2 (L3) (3,5-DBCat is dianion 3,5-di-tert-butylcatecolate)-were synthesized and characterized in detail. The exchange reaction between catechols L1 and L3 with triphenylantimony(V) dibromide in the presence of triethylamine leads to the corresponding triphenylantimony(V) catecholates (6-(CH2-S-tBu2Phenol)-3,5-DBCat)SbPh3 (1) and (6-(S-Phenol)-3,5-DBCat)SbPh3 (2). The electrochemical properties of catechols L1-L3 and catecholates 1 and 2 were investigated using cyclic voltammetry. The electrochemical oxidation of L1-L3 at the first stage proceeds with the formation of the corresponding o-benzoquinones. The second process is the oxidation of the phenolic moiety. Complexes 1 and 2 significantly expand their redox capabilities, owing to the fact that they can act as the electron donors due to the catecholate metallocycle capable of sequential oxidations, and as donors of the hydrogen atoms, thus forming a stable phenoxyl radical. The molecular structures of the free ligand L1 and complex 1 in the crystal state were determined by single-crystal X-ray analysis.


Subject(s)
Antimony/chemistry , Catechols/chemistry , Catechols/chemical synthesis , Phenols/chemistry , Crystallography, X-Ray , Electrochemical Techniques , Electrochemistry , Molecular Structure , Oxidation-Reduction , Sulfides/chemistry
14.
Soft Matter ; 16(13): 3257-3266, 2020 Apr 01.
Article in English | MEDLINE | ID: mdl-32163076

ABSTRACT

Clickable magnetic nanoparticles have attracted great attention as potential nanoplatforms for biomedical applications because of the high functionalization efficiency of their surfaces with biomolecules, which facilitates their bio-compatibilization. However, the design and synthesis of clickable NPs is still challenging because of the complexity of the chemistry on the magnetic NP surface, thus robust methods that improve the ligand synthesis and the transfer of magnetic NPs in physiological media being in high-demand. In this work, we developed a versatile and enhanced synthetic route to fabricate potentially clickable IONPs of interest in nanomedicine. Catechol anchor ligands with different stereo-electronic features were synthetized from a hetero bi-functional PEG spacer backbone. The resulting catechol ligands transferred in good yields and high stability to magnetic NPs by an improved energetic ligand exchange method that combines sonication and high temperature. The azido functionalized IONPs exhibited excellent characteristics as T2 MRI contrast agents with low cytotoxicity, making these clickable magnetic NPs promising precursors for nanomedicines.


Subject(s)
Catechols/chemistry , Click Chemistry , Ferric Compounds/chemistry , Metal Nanoparticles/chemistry , Catechols/chemical synthesis , Ligands
15.
Curr Top Med Chem ; 20(2): 161-169, 2020.
Article in English | MEDLINE | ID: mdl-31880263

ABSTRACT

BACKGROUND: Effective cancer treatment is a major public health challenge. The limitations of current therapies and their adverse effects reduce the efficacy of treatment, leading to significant mortality rates worldwide. Moreover, natural product chemistry occupies a prominent role in the search for new treatment alternatives, by contributing a spectrum of chemical structures that may potentially yield new bioactive compounds. The compound [6]-gingerol (1) is the main active substance in ginger (Zingiber officinale) and several studies have shown it to produce beneficial effects, including antitumor activity. OBJECTIVE: This work aims to obtain new gingerol derivatives with cytotoxic activity. METHODS: [6]-gingerol was isolated and its derivatives were produced using click chemistry, obtaining eight new compounds. All chemical structures were determined by means of IR, NMR and HRMS data, and cytotoxicity was evaluated in the HCT 116 (colon carcinoma) and MCF-7 (breast carcinoma) cell lines at concentrations of 5 µmol L-1 and 50 µmol L-1. RESULTS: At 50 µmol L-1, more than 70% inhibition of cell growth was achieved with compounds 2e, 2g against HCT 116, and 2b, 2d, 2e, 2f and 2g against MCF-7. CONCLUSION: The obtained compounds showed only moderate cytotoxic activity. However, the products with substituents occupying the meta position in relation to the triazole ring showed increased cytotoxic properties. The brominated compound (2g) showed the strongest activity, inhibiting cell proliferation by 87%.


Subject(s)
Antineoplastic Agents/pharmacology , Catechols/pharmacology , Fatty Alcohols/pharmacology , Triazoles/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Catechols/chemical synthesis , Catechols/chemistry , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Fatty Alcohols/chemical synthesis , Fatty Alcohols/chemistry , HCT116 Cells , Humans , MCF-7 Cells , Molecular Structure , Structure-Activity Relationship , Triazoles/chemical synthesis , Triazoles/chemistry
16.
J Org Chem ; 84(23): 15165-15172, 2019 12 06.
Article in English | MEDLINE | ID: mdl-31692354

ABSTRACT

cis-Dihydrodiols, derived from monocyclic aromatic compounds, are valuable chiral pool intermediates for the synthesis of cyclic natural products. A drawback of this approach, to the synthesis of polycyclic secondary metabolites, is that additional rings must be annulated. To date, relatively few chiral natural products have been synthesized from polycyclic arene cis-dihydrodiols. Fungal metabolites, (-)-ribisins A and B, have now been obtained by functional group manipulation of a tricyclic arene metabolite, obtained from toluene dioxygenase-catalyzed regioselective and stereoselective cis-dihydroxylations of dibenzo[b,d]furan. The synthetic sequences were marginally shorter than the alternative routes, using monocyclic arene cis-dihydrodiols, and required no carbon-carbon bond-forming reactions.


Subject(s)
Catechols/chemistry , Furans/chemistry , Catechols/chemical synthesis , Molecular Conformation , Stereoisomerism
17.
J Nat Prod ; 82(11): 2986-2993, 2019 11 22.
Article in English | MEDLINE | ID: mdl-31625751

ABSTRACT

A green, biomimetic, phosphate-mediated Pictet-Spengler reaction was used in the synthesis of three catecholic tetrahydroisoquinolines, 1, 2, and 12, present in the medicinal plant Portulaca oleracea, as well as their analogues 3-11, 13, and 14, with dopamine hydrochloride and aldehydes as the substrates. AB-8 macroporous resin column chromatography was applied for purification of the products from the one-step high-efficacy synthesis. It eliminated the difficulties in the isolation of catecholic tetrahydroisoquinolines from the aqueous reaction system and unreacted dopamine hydrochloride. Activity screening in CHO-K1/Gα15 cell models consistently expressing α1B-, ß1-, or ß2-adrenergic receptors indicated that 12 and 2, compounds that are present in P. oleracea, possessed the most potent ß2-adrenergic receptor agonist activity and 2 was a selective ß2-adrenergic receptor agonist at the concentration of 100 µM. Both 12 and 2 exhibited dose-dependent bronchodilator effects on the histamine-induced contraction of isolated guinea-pig tracheal smooth muscle, with EC50 values of 0.8 and 2.8 µM, respectively. These findings explain the scientific rationale of P. oleracea use as an antiasthmatic herb in folk medicine and provide the basis for the discovery of novel antiasthma drugs.


Subject(s)
Adrenergic beta-2 Receptor Agonists/chemical synthesis , Adrenergic beta-2 Receptor Agonists/pharmacology , Anti-Asthmatic Agents/chemical synthesis , Anti-Asthmatic Agents/pharmacology , Bronchodilator Agents/chemical synthesis , Bronchodilator Agents/pharmacology , Catechols/chemical synthesis , Catechols/pharmacology , Isoquinolines/chemical synthesis , Isoquinolines/pharmacology , Portulaca/chemistry , Aldehydes/chemistry , Animals , CHO Cells , Cricetulus , Dopamine/chemistry , Dose-Response Relationship, Drug , Guinea Pigs , In Vitro Techniques , Molecular Structure , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Trachea/drug effects
18.
Bioorg Med Chem ; 27(17): 3805-3812, 2019 09 01.
Article in English | MEDLINE | ID: mdl-31326241

ABSTRACT

The antiproliferative action of hispolon derivatives is stronger than that of related curcumin against several tumor cell lines. Hispolon size, smaller than curcumin, fits better than curcumin into the active site of HDAC6, an enzyme involved in deacetylation of lysine residues. HDACs are considered potential targets for tumor drug discovery and hydroxamates are known inhibitors of HDACs. One of them, SAHA (Vorinostat) is used in clinical studies. Investigations into possible mechanisms for hispolon derivatives active against the HCT116 colon tumor cell line are done after examining the structural results obtained from hispolon X-ray crystal structures as well as performing associated computational docking and Density Functional Theory techniques on HDAC6. These studies show preference for the HDAC6 active site by chelating the Zn center, in contrast with other ineffective hispolon derivatives, that establish only a single bond to the metal center. Structure activity relationships make clear that hydrogenation of the hispolon bridge also leads to single bond (non chelate) hispolon-Zn binding, and consistently nullifies the antiproliferative action against HCT116 tumor.


Subject(s)
Antineoplastic Agents/pharmacology , Catechols/pharmacology , Density Functional Theory , Histone Deacetylase Inhibitors/pharmacology , Histone Deacetylases/metabolism , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Catechols/chemical synthesis , Catechols/chemistry , Cell Proliferation/drug effects , Cell Survival/drug effects , Crystallography, X-Ray , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , HCT116 Cells , Histone Deacetylase Inhibitors/chemical synthesis , Histone Deacetylase Inhibitors/chemistry , Humans , Models, Molecular , Molecular Structure , Structure-Activity Relationship
19.
J Org Chem ; 84(10): 6459-6464, 2019 05 17.
Article in English | MEDLINE | ID: mdl-31039303

ABSTRACT

Here, we report the first total synthesis of hinduchelins A-D, a family of nontoxic catechol derivatives from Streptoalloteichus hindustanus, possessing a druglike chemotype and modest iron-chelating ability. A concise synthesis was developed employing methyl 5-methyloxazole-4-carboxylate as a single starting material to provide hinduchelins A-D (and unnatural analogues) in only four steps and 5-15% overall yields; moreover, the stereochemistry of hinduchelin A was reassigned from ( S) to ( R). Biological evaluation confirmed that natural and unnatural hinduchelins are weak iron chelators (siderophores).


Subject(s)
Catechols/chemistry , Catechols/chemical synthesis , Iron Chelating Agents/chemistry , Iron Chelating Agents/chemical synthesis , Actinobacteria/chemistry , Chemistry Techniques, Synthetic , Stereoisomerism
20.
Bioorg Chem ; 89: 103003, 2019 08.
Article in English | MEDLINE | ID: mdl-31132599

ABSTRACT

A number of asymmetrical thioethers based on 3,5-di-tert-butylcatechol containing sulfur atom bonding with physiologically active groups in the sixth position of aromatic ring have been synthesized and the electrochemical properties, antioxidant, cryoprotective activities of new thioethers have been evaluated. Cyclic voltammetry was used to estimate the oxidation potentials of thioethers in acetonitrile. The electrooxidation of compounds at the first stage leads to the formation of o-benzoquinones. The antioxidant activities of the compounds were determined using 2,2'-diphenyl-1-picrylhydrazyl radical (DPPH) assay, experiments on the oxidative damage of the DNA, the reaction of 2,2'-azobis(2-amidinopropane hydrochloride) (AAPH) induced glutathione depletion (GSH), the process of lipid peroxidation of rat liver (Wistar) homogenates in vitro, and iron(II) chelation test. Compounds 1-9 have greater antioxidant effectiveness than 3,5-di-tert-butylcatechol (CatH2) in all assays. The variation of physiologically active groups at sulfur atom allows to regulate lipophilic properties and antioxidant activity of compounds. Thioethers 3, 4 and 7 demonstrate the combination of radical scavenging, antioxidant activity and iron(II) binding properties. The researched compounds 1-9 were studied as possible cryoprotectants of the media for cryopreservation of the Russian sturgeon sperm. Novel cryoprotective additives in cryomedium reduce significantly the content of membrane-permeating agent (DMSO). A cryoprotective effect of an addition of the catechol thioethers depends on the structure of groups at sulfur atom. The cryoprotective properties of compounds 3, 4 and 7 are caused by combination of catechol fragment, bonded by a thioether linker with a long hydrocarbon chain and a terminal ionizable group or with a biologically relevant acetylcysteine residue.


Subject(s)
Antioxidants/pharmacology , Catechols/pharmacology , Cryoprotective Agents/pharmacology , Sperm Motility/drug effects , Spermatozoa/drug effects , Sulfides/pharmacology , Animals , Antioxidants/chemical synthesis , Antioxidants/chemistry , Catechols/chemical synthesis , Catechols/chemistry , Cryoprotective Agents/chemical synthesis , Cryoprotective Agents/chemistry , Dose-Response Relationship, Drug , Fishes , Lipid Peroxidation/drug effects , Male , Molecular Structure , Oxidation-Reduction , Rats , Rats, Wistar , Structure-Activity Relationship , Sulfides/chemical synthesis , Sulfides/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...